Front-line health care workers across the country are receiving the first COVID-19 vaccinations. With the recent approval of a second COVID-19 vaccine for use here in the U.S., more COVID-19 vaccine doses are expected to be available this week.
A Centers for Disease Control and Prevention panel has recommended allocating COVID-19 vaccines for the next phase. Phase 1b includes those who are 75 and older as well as front-line essential workers, including police, firefighters, teachers and grocery store workers. These vaccinations would begin when phase 1a, health care workers and long term care residents, is completed.
On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, gives an update on vaccine approvals and the rollout phases.
This interview was recorded on Dec. 21, 2020. For the safety of its patients, staff and visitors, Mayo Clinic has strict masking policies in place. Anyone shown without a mask was recorded prior to COVID-19 or recorded in an area not designated for patient care, where social distancing and other safety protocols were followed.
Information in this post was accurate at the time of its posting. Due to the fluid nature of the COVID-19 pandemic, scientific understanding along with guidelines and recommendations may have changed since the original publication date. For more information and all your COVID-19 coverage, go to the Mayo Clinic News Network: [ Ссылка ]
Dr. Poland has served as a consultant for Merck & Co. Inc., Medicago Inc., GlaxoSmithKline plc, Sanofi Pasteur, Emergent BioSolutions Inc., Dynavax Technologies Corp., Genentech Inc., Eli Lilly and Co., Kentucky BioProcessing Inc. and Genevant Sciences Corp., and Janssen Pharmaceuticals Inc. He is a paid scientific adviser for Johnson & Johnson. Honoraria: Elsevier.
